{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:55:52Z","timestamp":1792000552024,"version":"4.4.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T00:00:00Z","timestamp":1600905600000},"content-version":"vor","delay-in-days":3495,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["mcponline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular &amp; Cellular Proteomics"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1074\/mcp.m110.002477","type":"journal-article","created":{"date-parts":[[2010,11,17]],"date-time":"2010-11-17T00:09:13Z","timestamp":1289952553000},"page":"M110.002477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Peptides Presented by HLA-DR Molecules in Synovia of Patients with Rheumatoid Arthritis or Antibiotic-Refractory Lyme Arthritis"],"prefix":"10.1016","volume":"10","author":[{"given":"Robert J.","family":"Seward","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise E.","family":"Drouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen C.","family":"Steere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine E.","family":"Costello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/mcp.M110.002477_bib1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nri1267","article-title":"Elucidation of Lyme arthritis","volume":"4","author":"Steere","year":"2004","journal-title":"Nat. Rev. Immunol"},{"key":"10.1074\/mcp.M110.002477_bib2","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1002\/art.22131","article-title":"Therapy for Lyme arthritis; strategies for the treatment of antibiotic-refractory arthritis","volume":"54","author":"Steere","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1074\/mcp.M110.002477_bib3","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/art.1780310405","article-title":"Spirochetal antigens and lymphoid cell surface markers in Lyme synovitis: comparison with rheumatoid synovium and tonsillar lymphoid tissue","volume":"31","author":"Steere","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1074\/mcp.M110.002477_bib4","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.4049\/jimmunol.167.2.1072","article-title":"Lymphoid neogenesis in rheumatoid synovitis","volume":"167","author":"Takemura","year":"2001","journal-title":"J. Immunol"},{"key":"10.1074\/mcp.M110.002477_bib5","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1399-0004.1989.tb03185.x","article-title":"The contribution of HLA to rheumatoid arthritis","volume":"36","author":"Deighton","year":"1989","journal-title":"Clin. Genet"},{"key":"10.1074\/mcp.M110.002477_bib6","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/1529-0131(199906)42:6<1071::AID-ANR1>3.0.CO;2-8","article-title":"The genetics revolution and the assault on rheumatoid arthritis","volume":"42","author":"Seldin","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1074\/mcp.M110.002477_bib7","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1084\/jem.20052471","article-title":"Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide","volume":"203","author":"Steere","year":"2006","journal-title":"J. Exp. Med"},{"key":"10.1074\/mcp.M110.002477_bib8","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/art.1780301102","article-title":"The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis","volume":"30","author":"Gregersen","year":"1987","journal-title":"Arthritis Rheum"},{"key":"10.1074\/mcp.M110.002477_bib9","doi-asserted-by":"crossref","first-page":"801","DOI":"10.7326\/0003-4819-117-10-801","article-title":"The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis","volume":"117","author":"Weyand","year":"1992","journal-title":"Ann. Intern. Med"},{"key":"10.1074\/mcp.M110.002477_bib10","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/art.1780381202","article-title":"Polyglot and polymorphism: an HLA update","volume":"38","author":"Nepom","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1074\/mcp.M110.002477_bib11","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","article-title":"Evolving concepts of rheumatoid arthritis","volume":"423","author":"Firestein","year":"2003","journal-title":"Nature"},{"key":"10.1074\/mcp.M110.002477_bib12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri724","article-title":"Epitope spreading in immune-mediated diseases: implications for immunotherapy","volume":"2","author":"Vanderlugt","year":"2002","journal-title":"Nat. Rev. Immunol"},{"key":"10.1074\/mcp.M110.002477_bib13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.0105-2896.2005.00245.x","article-title":"Rheumatoid arthritis","volume":"204","author":"Goronzy","year":"2005","journal-title":"Immunol. Rev"},{"key":"10.1074\/mcp.M110.002477_bib14","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/ar2370","article-title":"Recent developments in the immunobiology of rheumatoid arthritis","volume":"10","author":"Andersson","year":"2008","journal-title":"Arthritis Res. Ther"},{"key":"10.1074\/mcp.M110.002477_bib15","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.molimm.2007.04.017","article-title":"Human homologues of a Borrelia T cell epitope associated with antibiotic-refractory Lyme arthritis","volume":"45","author":"Drouin","year":"2008","journal-title":"Mol. Immunol"},{"key":"10.1074\/mcp.M110.002477_bib16","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1126\/science.1546328","article-title":"Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry","volume":"255","author":"Hunt","year":"1992","journal-title":"Science"},{"key":"10.1074\/mcp.M110.002477_bib17","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/eji.1830250553","article-title":"Purification and characterization of endogenous peptides extracted from HLA-DR isolated from the spleen of a patient with rheumatoid arthritis","volume":"25","author":"Gordon","year":"1995","journal-title":"Eur. J. Immunol"},{"key":"10.1074\/mcp.M110.002477_bib18","first-page":"99","article-title":"Analysis of intestinal HLA-DR bound peptides and dysregulated immune responses to enteric flora in the pathogenesis of inflammatory bowel disease","volume":"11","author":"Oshitani","year":"2003","journal-title":"Int. J. Mol. Med"},{"key":"10.1074\/mcp.M110.002477_bib19","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1158\/1078-0432.CCR-05-2470","article-title":"Unexpected abundance of HLA class II presented peptides in primary renal cell carcinomas","volume":"12","author":"Dengjel","year":"2006","journal-title":"Clin. Cancer Res"},{"key":"10.1074\/mcp.M110.002477_bib20","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1172\/JCI32401","article-title":"Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis","volume":"117","author":"Wahlstr\u00f6m","year":"2007","journal-title":"J. Clin. Investig"},{"key":"10.1074\/mcp.M110.002477_bib21","doi-asserted-by":"crossref","first-page":"795","DOI":"10.4049\/jimmunol.181.1.795","article-title":"Thyroglobulin peptides associate in vivo to HLA-DR in autoimmune thyroid glands","volume":"181","author":"Muix\u00ed","year":"2008","journal-title":"J. Immunol"},{"key":"10.1074\/mcp.M110.002477_bib22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1074\/mcp.M110.002477_bib23","first-page":"1","article-title":"Case definitions for public health surveillance","volume":"39","author":"Wharton","year":"1990","journal-title":"MMWR Recomm. Rep"},{"key":"10.1074\/mcp.M110.002477_bib24","first-page":"590","article-title":"Recommendations for test performance and interpretation from the Second International Conference on Serologic Diagnosis of Lyme Disease","volume":"44","author":"Centers for Disease Control and Prevention (CDC)","year":"1995","journal-title":"MMWR Morb. Mortal. Wkly. Rep"},{"key":"10.1074\/mcp.M110.002477_bib25","series-title":"ASHI Laboratory Manual","first-page":"8.1","article-title":"HLA-DR sequence-based typing","author":"Baxter-Lowe","year":"2000"},{"key":"10.1074\/mcp.M110.002477_bib26","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1074\/mcp.M900001-MCP200","article-title":"Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients","volume":"8","author":"Fissolo","year":"2009","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.M110.002477_bib27","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/9858","article-title":"Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices","volume":"17","author":"Sturniolo","year":"1999","journal-title":"Nat. Biotechnol"},{"key":"10.1074\/mcp.M110.002477_bib28","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1002\/1529-0131(199912)42:12<2705::AID-ANR29>3.0.CO;2-H","article-title":"Lack of Borrelia burgdorferi DNA in synovial samples in patients with antibiotic treatment-resistant Lyme arthritis","volume":"42","author":"Carlson","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1074\/mcp.M110.002477_bib29","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nmeth1019","article-title":"Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry","volume":"4","author":"Elias","year":"2007","journal-title":"Nat. Methods"},{"key":"10.1074\/mcp.M110.002477_bib30","doi-asserted-by":"crossref","first-page":"R161","DOI":"10.1186\/ar1153","article-title":"The synovial proteome: analysis of fibroblast-like synoviocytes","volume":"6","author":"Dasuri","year":"2004","journal-title":"Arthritis Res. Ther"},{"key":"10.1074\/mcp.M110.002477_bib31","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1002\/pmic.200401109","article-title":"Chronically inflamed synovium from spondyloarthropathy and rheumatoid arthritis investigated by protein expression profiling followed by tandem mass spectrometry","volume":"5","author":"Tilleman","year":"2005","journal-title":"Proteomics"},{"key":"10.1074\/mcp.M110.002477_bib32","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/rheumatology\/kei023","article-title":"Citrullination of fibronectin in rheumatoid arthritis synovial tissue","volume":"44","author":"Chang","year":"2005","journal-title":"Rheumatology"},{"key":"10.1074\/mcp.M110.002477_bib33","series-title":"Rheumatology","first-page":"819","article-title":"Autoantibodies in rheumatoid arthritis","author":"Steiner","year":"2008"},{"key":"10.1074\/mcp.M110.002477_bib34","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0952-7915(95)80033-6","article-title":"Chemistry of peptides associated with MHC class I and class II molecules","volume":"7","author":"Rammensee","year":"1995","journal-title":"Curr. Opin. Immunol"},{"key":"10.1074\/mcp.M110.002477_bib35","doi-asserted-by":"crossref","first-page":"e1000048","DOI":"10.1371\/journal.pcbi.1000048","article-title":"A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach","volume":"4","author":"Wang","year":"2008","journal-title":"PLoS Comput. Biol"},{"key":"10.1074\/mcp.M110.002477_bib36","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI1316","article-title":"Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies","volume":"101","author":"Schellekens","year":"1998","journal-title":"J. Clin. Investig"},{"key":"10.1074\/mcp.M110.002477_bib37","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","article-title":"The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide","volume":"43","author":"Schellekens","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1074\/mcp.M110.002477_bib38","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/ard.2008.091355","article-title":"Multiple antibody reactivities to citrullinated antigens in sera from rheumatoid arthritis patients\u2014association with HLA-DRB1 alleles","volume":"68","author":"Snir","year":"2009","journal-title":"Ann. Rheum. Dis"},{"key":"10.1074\/mcp.M110.002477_bib39","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1172\/JCI33997","article-title":"The saga of MHC-bound peptides: a renaissance for antigen presentation?","volume":"117","author":"Teyton","year":"2007","journal-title":"J. Clin. Investig"},{"key":"10.1074\/mcp.M110.002477_bib40","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/BF00188785","article-title":"Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules","volume":"39","author":"Falk","year":"1994","journal-title":"Immunogenetics"},{"key":"10.1074\/mcp.M110.002477_bib41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1084\/jem.178.1.27","article-title":"Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles","volume":"178","author":"Chicz","year":"1993","journal-title":"J. Exp. Med"},{"key":"10.1074\/mcp.M110.002477_bib42","doi-asserted-by":"crossref","first-page":"5089","DOI":"10.4049\/jimmunol.169.9.5089","article-title":"Analysis of MHC class II antigen processing by quantitation of peptides that constitute nested sets","volume":"169","author":"Lippolis","year":"2002","journal-title":"J. Immunol"},{"key":"10.1074\/mcp.M110.002477_bib43","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.coi.2009.01.013","article-title":"Macroautophagy, endogenous MHC II loading and T cell selection: the benefits of breaking the rules","volume":"21","author":"Nedjic","year":"2009","journal-title":"Curr. Opin. Immunol"},{"key":"10.1074\/mcp.M110.002477_bib44","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1042\/bj3400467","article-title":"Stable expression of protective protein\/cathepsin A-green fluorescent protein fusion genes in a fibroblastic cell line from a galactosialidosis patient. Model system for revealing the intracellular transport of normal and mutated lysosomal enzymes","volume":"340","author":"Naganawa","year":"1999","journal-title":"Biochem. J"},{"key":"10.1074\/mcp.M110.002477_bib45","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.coi.2005.11.011","article-title":"Endosomal proteases in antigen presentation","volume":"18","author":"Chapman","year":"2006","journal-title":"Curr. Opin. Immunol"},{"key":"10.1074\/mcp.M110.002477_bib46","doi-asserted-by":"crossref","first-page":"18769","DOI":"10.1073\/pnas.1008501107","article-title":"Soluble plasma HLA peptidome as a potential source for cancer biomarkers","volume":"107","author":"Bassani-Sternberg","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/mcp.M110.002477_bib47","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1002\/art.21419","article-title":"Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles","volume":"52","author":"Irigoyen","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1074\/mcp.M110.002477_bib48","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1002\/art.21302","article-title":"Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis","volume":"52","author":"Verpoort","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1074\/mcp.M110.002477_bib49","first-page":"219","article-title":"Differential association of HLA-DRB1 alleles in Japanese patients with early rheumatoid arthritis in relationship to autoantibodies to cyclic citrullinated peptide","volume":"25","author":"Furuya","year":"2007","journal-title":"Clin. Exp. Rheumatol"},{"key":"10.1074\/mcp.M110.002477_bib50","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1002\/art.21220","article-title":"Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase as pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunity","volume":"52","author":"De Rycke","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1074\/mcp.M110.002477_bib51","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1084\/jem.189.11.1757","article-title":"Modification of cysteine residues in vitro and in vivo affects the immunogenicity and antigenicity of major histocompatibility complex class I-restricted viral determinants","volume":"189","author":"Chen","year":"1999","journal-title":"J. Exp. Med"},{"key":"10.1074\/mcp.M110.002477_bib52","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.4049\/jimmunol.166.7.4543","article-title":"Cysteinylation of MHC class II ligands: peptide endocytosis and reduction within APC influences T cell recognition","volume":"166","author":"Haque","year":"2001","journal-title":"J. Immunol"},{"key":"10.1074\/mcp.M110.002477_bib53","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1074-7613(00)80330-1","article-title":"The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition","volume":"6","author":"Meadows","year":"1997","journal-title":"Immunity"},{"key":"10.1074\/mcp.M110.002477_bib54","doi-asserted-by":"crossref","first-page":"6360","DOI":"10.4049\/jimmunol.163.12.6360","article-title":"Cutting edge: the HLA-A*0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique","volume":"163","author":"Pierce","year":"1999","journal-title":"J. Immunol"},{"key":"10.1074\/mcp.M110.002477_bib55","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0952-7915(00)00166-7","article-title":"Antigen-specific therapy for autoimmune disease","volume":"12","author":"Harrison","year":"2000","journal-title":"Curr. Opin. Immunol"},{"key":"10.1074\/mcp.M110.002477_bib56","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1073\/pnas.0400061101","article-title":"Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis","volume":"101","author":"Prakken","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A"}],"container-title":["Molecular &amp; Cellular Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947620324968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947620324968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/mcp.M110.002477","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:39:30Z","timestamp":1761525570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535947620324968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S1535947620324968"],"URL":"https:\/\/doi.org\/10.1074\/mcp.m110.002477","relation":{},"ISSN":["1535-9476"],"issn-type":[{"value":"1535-9476","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peptides Presented by HLA-DR Molecules in Synovia of Patients with Rheumatoid Arthritis or Antibiotic-Refractory Lyme Arthritis","name":"articletitle","label":"Article Title"},{"value":"Molecular & Cellular Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/mcp.M110.002477","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"M110.002477"}}